{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T19:10:38Z","timestamp":1762542638233,"version":"build-2065373602"},"reference-count":31,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.clgc.2017.03.005","type":"journal-article","created":{"date-parts":[[2017,3,18]],"date-time":"2017-03-18T15:01:03Z","timestamp":1489849263000},"page":"704-710","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Patient-reported Quality of Life After Proton Beam Therapy for Prostate Cancer: The Effect of\u00a0Prostate Size"],"prefix":"10.1016","volume":"15","author":[{"given":"Anuj","family":"Goenka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil B.","family":"Newman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiral","family":"Fontanilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oren","family":"Cahlon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Chon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugen","family":"Hug","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahul R.","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clgc.2017.03.005_bib1","first-page":"9","article-title":"Cancer statistics, 2014","volume":"64","author":"Siegel","year":"2014","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.clgc.2017.03.005_bib2","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ijrobp.2007.07.2335","article-title":"Dose-volume comparison of proton therapy and intensity-modulated radiotherapy for prostate cancer","volume":"70","author":"Vargas","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clgc.2017.03.005_bib3","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1001\/jama.2010.287","article-title":"Patient-reported long-term outcomes after conventional and high-dose combined proton and photon radiation for early prostate cancer","volume":"303","author":"Talcott","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.clgc.2017.03.005_bib4","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.ijrobp.2007.04.075","article-title":"Rectal dose-volume differences using proton radiotherapy and a rectal balloon or water alone for the treatment of prostate cancer","volume":"69","author":"Vargas","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clgc.2017.03.005_bib5","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1200\/JCO.2009.25.8475","article-title":"Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from Proton Radiation Oncology Group\/American College of Radiology 95-09","volume":"28","author":"Zietman","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clgc.2017.03.005_bib6","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1001\/jama.2012.460","article-title":"Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer","volume":"307","author":"Sheets","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.clgc.2017.03.005_bib7","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ijrobp.2007.05.051","article-title":"Toxicity profile with a large prostate volume after external beam radiotherapy for localized prostate cancer","volume":"70","author":"Pinkawa","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clgc.2017.03.005_bib8","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0302-2838(03)00134-9","article-title":"The impact of prostate volume following neoadjuvant androgen deprivation on quality of life and voiding symptoms in patients undergoing permanent prostate brachytherapy","volume":"43","author":"Krupski","year":"2003","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2017.03.005_bib9","first-page":"29","article-title":"Effect of pretreatment prostate volume on urinary quality of life following intensity-modulated radiation therapy for localized prostate cancer","volume":"5","author":"Chevli","year":"2013","journal-title":"Res Rep Urol"},{"key":"10.1016\/j.clgc.2017.03.005_bib10","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ijrobp.2009.11.023","article-title":"The impact of pretreatment prostate volume on severe acute genitourinary toxicity in prostate cancer patients treated with\u00a0intensity-modulated radiation therapy","volume":"79","author":"Aizer","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3A\u00a0suppl","key":"10.1016\/j.clgc.2017.03.005_bib11","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0090-4295(97)00168-4","article-title":"Neoadjuvant androgen ablation prior to radiotherapy for prostate cancer: reducing the potential morbidity of therapy","volume":"49","author":"Zelefsky","year":"1997","journal-title":"Urology"},{"key":"10.1016\/j.clgc.2017.03.005_bib12","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3109\/07357909509024889","article-title":"Neoadjuvant hormonal downsizing of localized carcinoma of the prostate: effects on the volume of normal tissue irradiation","volume":"13","author":"Forman","year":"1995","journal-title":"Cancer Invest"},{"key":"10.1016\/j.clgc.2017.03.005_bib13","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/COC.0b013e3181841f13","article-title":"Proton therapy for prostate cancer treatment employing online image guidance and an action level threshold","volume":"32","author":"Vargas","year":"2009","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.clgc.2017.03.005_bib14","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0090-4295(00)00858-X","article-title":"Development and validation of the Expanded Prostate Cancer Index Composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer","volume":"56","author":"Wei","year":"2000","journal-title":"Urology"},{"key":"10.1016\/j.clgc.2017.03.005_bib15","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1056\/NEJMoa074311","article-title":"Quality of life and satisfaction with outcome among prostate-cancer survivors","volume":"358","author":"Sanda","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clgc.2017.03.005_bib16","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.ijrobp.2013.07.041","article-title":"Preliminary toxicity analysis of 3-dimensional conformal radiation therapy versus intensity modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology Group 0126 prostate cancer trial","volume":"87","author":"Michalski","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clgc.2017.03.005_bib17","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S0360-3016(02)02829-8","article-title":"Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial","volume":"53","author":"Pollack","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clgc.2017.03.005_bib18","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ijrobp.2007.06.054","article-title":"Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer","volume":"70","author":"Kuban","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clgc.2017.03.005_bib19","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1001\/jama.294.10.1233","article-title":"Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial","volume":"294","author":"Zietman","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.clgc.2017.03.005_bib20","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1470-2045(07)70143-2","article-title":"Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial","volume":"8","author":"Dearnaley","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clgc.2017.03.005_bib21","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1200\/JCO.2005.05.2530","article-title":"Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy","volume":"24","author":"Peeters","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clgc.2017.03.005_bib22","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.ijrobp.2004.07.715","article-title":"Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy","volume":"61","author":"Peeters","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clgc.2017.03.005_bib23","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.ijrobp.2004.12.052","article-title":"Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy","volume":"62","author":"Vargas","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clgc.2017.03.005_bib24","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0360-3016(94)90563-0","article-title":"Neoadjuvant hormonal therapy improves the therapeutic ratio in patients with bulky prostatic cancer treated with three-dimensional conformal radiation therapy","volume":"29","author":"Zelefsky","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clgc.2017.03.005_bib25","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1080\/0891060310002177","article-title":"Changes in treatment volume of hormonally treated and untreated cancerous prostate and its impact on rectal dose","volume":"42","author":"Lilleby","year":"2003","journal-title":"Acta Oncol"},{"key":"10.1016\/j.clgc.2017.03.005_bib26","doi-asserted-by":"crossref","first-page":"470","DOI":"10.3109\/0284186X.2012.744467","article-title":"Outcomes in men with large prostates (\u226560 cm(3)) treated with definitive proton therapy for prostate cancer","volume":"52","author":"McGee","year":"2013","journal-title":"Acta Oncol"},{"key":"10.1016\/j.clgc.2017.03.005_bib27","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1056\/NEJM199707313370502","article-title":"Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin","volume":"337","author":"Bolla","year":"1997","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clgc.2017.03.005_bib28","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.ijrobp.2004.10.021","article-title":"Long-term androgen deprivation increases grade 2 and higher late morbidity in prostate cancer patients treated with three-dimensional conformal radiation therapy","volume":"62","author":"Feigenberg","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clgc.2017.03.005_bib29","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0360-3016(96)00468-3","article-title":"Late GI and GU complications in the treatment of prostate cancer","volume":"37","author":"Schultheiss","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clgc.2017.03.005_bib30","first-page":"947","article-title":"Quality of life after treatment for localized prostate cancer: differences based on treatment modality","volume":"166","author":"Davis","year":"2001","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.clgc.2017.03.005_bib31","doi-asserted-by":"crossref","first-page":"3972","DOI":"10.1200\/JCO.2003.11.023","article-title":"Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: the Radiation Therapy Oncology Group Protocol 92-02","volume":"21","author":"Hanks","year":"2003","journal-title":"J\u00a0Clin Oncol"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767317300678?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767317300678?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T11:28:30Z","timestamp":1761564510000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767317300678"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S1558767317300678"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2017.03.005","relation":{},"ISSN":["1558-7673"],"issn-type":[{"type":"print","value":"1558-7673"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient-reported Quality of Life After Proton Beam Therapy for Prostate Cancer: The Effect of\u00a0Prostate Size","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2017.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}